As people grow older and nutrients, sunlight, influence of environmental factors, human synthesis of hyaluronic acid (Restylane) decreasing capacity HA, hyaluronic acid in the skin (hyaluronic acid) may decrease the content of HA, in the embryonic stages of hyaluronic acid in the body (hyaluronic acid) HA the highest decrease after birth. When 20 year old body's hyaluronic acid (Restylane) relative content positioning 100% HA, 30, 50, 60 years old respectively, and 65%, and 25%. When hyaluronic acid in the skin (hyaluronic acid) HA content falls below a certain level, the layer of skin moisture content decreases, causing aging stratum corneum, skin becomes rough, wrinkles, loss of elasticity, is aging, this phenomenon generally occurs after the age of 25. This is the gap between older people and children's skin is one of the main reasons. While hyaluronic acid in the skin (hyaluronic acid) HA damage associated with UV, so long engaged in field operations, Highland life, outdoors than an indoor staff of the skin is rough.
Double-blind human clinical trials show that after oral administration of 4 hour, hyaluronic acid content in the blood significantly increased peak 12-hour, 70 times higher than the control group. Even served 7 days to reach stable concentration.
-
singclean | 2016-04-13Singclean Medical to Host Its First International Aesthetic Leadership Forum at IMCAS China 2025Singclean Medical to Host Its First International Aesthetic Leadership Forum at IMCAS China 2025 Uniting Global Experts to Shape the Future of Scientific Aesthetics
-
singclean | 2016-04-13Singclean Medical to Showcase Breakthrough Aesthetic Solutions at IMCAS China 2025Shanghai, China – Singclean Medical is proud to announce its participation in IMCAS China 2025, one of Asia’s leading congresses for medical aesthetics, taking place from July 11 to 13 at the Kerry Hotel Pudong, Shanghai.
-
singclean | 2016-04-13Singclean Medical shines at HOSPITALAR 2025: Deeply cultivate the Latin American medical market with R&D and intelligent manufacturingSao Paulo, Brazil —— Singclean Medical, a world-leading absorbable biomaterial company, appeared at HOSPITALAR 2025 in June 2025, bringing four major product lines including regenerative medical beauty, orthopedics, ophthalmology and surgical hemostasis, to systematically demonstrate its global strength driven by the dual core of "R&D + automation" to the Latin American market. As a benchmark exhibition in the Latin American medical industry, this HOSPITALAR brings together top companies from around the world. Singclean Medica has become one of the core concerns of professional audiences on site with its CE/NMPA/ANVISA multi-certified product matrix and localized cooperation results.